Executive Summary Ticlopidine

By Mann Ronald  

The Journal of Drug Evaluation, Vol. 2, Iss. 6, 2004-01 ,pp. : 161-161

Taylor & Francis Ltd

Access to resources Recommend Favorite

SYMPOSIUM ON PHARMACOKINETICS PHARMACODYNAMICS IN THE DEVELOPING SYSTEM AND IMPACT ON RISK ASSESSMENT EXECUTIVE SUMMARY

By Young John F   Schwetz Bernard A   Willhite Calvin C   Kacew Sam  

Journal of Toxicology and Environmental Health, Vol. 49, Iss. 4, 1996-11 ,pp. : 339-356

Taylor & Francis Ltd

Access to resources Recommend Favorite

CANADIAN NETWORK OF TOXICOLOGY CENTRES (CNTC) EXECUTIVE SUMMARY - ANNUAL RESEARCH SYMPOSIUM, 29-30 MARCH 1999

By Ritter Leonard   Hale Beverley   Krishnan Kannan   Kraak Glen Van Der   Warner Donna  

Journal of Toxicology and Environmental Health, Vol. 59, Iss. 7, 2000-04 ,pp. : 527-538

Taylor & Francis Ltd

Access to resources Recommend Favorite

Adaptive Designs in Clinical Drug Development—An Executive Summary of the PhRMA Working Group

By Gallo Paul  

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 3, 2006-05 ,pp. : 275-283

Taylor & Francis Ltd

Access to resources Recommend Favorite

Discussion of the “Executive Summary of the PhRMA Working Group on Adaptive Designs in Clinical Drug Development”

By Lokhnygina Yuliya  

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 3, 2006-05 ,pp. : 287-288

Taylor & Francis Ltd

Access to resources Recommend Favorite